Pojamide: An HDAC3-Selective Ferrocene Analogue with Remarkably Enhanced Redox-Triggered Ferrocenium Activity in Cells

A ferrocene containing o-aminoanilide, N1-(2-aminophenyl)-N8-ferrocenyloctanediamide (2b, Pojamide) displayed nanomolar potency vs HDAC3. In comparison to RGFP966, a potent and selective HDAC3 inhibitor, Pojamide displayed superior activity in HCT116 colorectal cancer cell invasion assays; however, TCH106 and romidepsin, potent HDAC1 inhibitors, outperformed Pojamide in cellular proliferation and colony formation assays. Together, these data suggest that HDAC1,3 inhibition is desirable to achieve maximum anticancer benefits. Additionally, we explored Pojamide-induced redox pharmacology. Indeed, treating HCT116 cells with Pojamide, SNP (sodium nitroprusside), and glutathione (GSH) led to greatly enhanced cytotoxicity and DNA damage, attributed to activation to an Fe(III) species.

[1]  T. R. Blower,et al.  Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors. , 2016, ChemPlusChem.

[2]  J. Spencer,et al.  Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells , 2016, International journal of molecular sciences.

[3]  G. Gasser,et al.  Selective Photorelease of an Organometallic-Containing Enzyme Inhibitor , 2016 .

[4]  A. Kozikowski,et al.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget? , 2016, ChemMedChem.

[5]  A. Vessières,et al.  Ferrocifen type anti cancer drugs. , 2015, Chemical Society reviews.

[6]  W. Thiel,et al.  Cyclopentadienide Ligand CpC– Possessing Intrinsic Helical Chirality and Its Ferrocene Analogues , 2015 .

[7]  S. Ferrari,et al.  Induction of Cytotoxicity through Photorelease of Aminoferrocene. , 2015, Inorganic chemistry.

[8]  N. Lamadema,et al.  Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit. , 2015, Journal of medicinal chemistry.

[9]  Yindi Jiang,et al.  HDAC3 controls gap 2/mitosis progression in adult neural stem/progenitor cells by regulating CDK1 levels , 2014, Proceedings of the National Academy of Sciences.

[10]  L. Ji,et al.  Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. , 2014, Chemical communications.

[11]  C. Mercurio,et al.  Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next , 2014, ChemMedChem.

[12]  Yizhi Liu,et al.  Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition in retinal pigment epithelium cells , 2014, Journal of cellular and molecular medicine.

[13]  M. Weïwer,et al.  Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia. , 2013, Future medicinal chemistry.

[14]  G. Jaouen,et al.  Synthesis, Characterization, and Antiproliferative Activities of Novel Ferrocenophanic Suberamides against Human Triple-Negative MDA-MB-231 and Hormone-Dependent MCF-7 Breast Cancer Cells , 2013 .

[15]  Zhuofeng Ke,et al.  Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents. , 2013, Chemistry.

[16]  P. Dyson,et al.  Enzyme inhibition by metal complexes: concepts, strategies and applications , 2013 .

[17]  G. Rogge,et al.  HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner , 2013, Proceedings of the National Academy of Sciences.

[18]  J. Bolaños,et al.  Glutathione and γ-glutamylcysteine in hydrogen peroxide detoxification. , 2013, Methods in enzymology.

[19]  J. Spencer,et al.  Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells. , 2012, Chemical research in toxicology.

[20]  B. Spingler,et al.  The [(Cp)M(CO)3] (M=Re, 99mTc) Building Block for Imaging Agents and Bioinorganic Probes: Perspectives and Limitations , 2012, Chemistry & biodiversity.

[21]  Simon J. Coles,et al.  Changing and challenging times for service crystallography , 2012 .

[22]  F. Wenz,et al.  Aminoferrocene-based prodrugs activated by reactive oxygen species. , 2012, Journal of medicinal chemistry.

[23]  N. L. La Thangue,et al.  HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications , 2012, Immunology and cell biology.

[24]  J. Schwabe,et al.  Structure of HDAC3 bound to corepressor and inositol tetraphosphate , 2011, Nature.

[25]  J. Bradner,et al.  Click JAHAs: Conformationally restricted ferrocene-based histone deacetylase inhibitors , 2012 .

[26]  Claudia Y Acevedo Morantes.  Cytotoxicity and Reactive Oxygen Species Generated by Ferrocenium and Ferrocene on MCF7 and MCF10A Cell Lines , 2012 .

[27]  Alexandru Almasan,et al.  Histone H2AX phosphorylation: a marker for DNA damage. , 2012, Methods in molecular biology.

[28]  Jahangir Amin,et al.  Synthesis and evaluation of metallocene containing methylidene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors. , 2011, Metallomics : integrated biometal science.

[29]  J. Bradner,et al.  Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors , 2011, ACS medicinal chemistry letters.

[30]  G. Gasser,et al.  Organometallic Anticancer Compounds , 2010, Journal of medicinal chemistry.

[31]  Y. Kagawa,et al.  Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide , 2010, Cancer science.

[32]  M. Pandolfo,et al.  Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model , 2010, PloS one.

[33]  James E. Bradner,et al.  Chemical Phylogenetics of Histone Deacetylases , 2010, Nature chemical biology.

[34]  Ruben Abagyan,et al.  A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway. , 2010, Cancer research.

[35]  M. Cascante,et al.  Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation , 2010, Metabolomics.

[36]  M. Morgan,et al.  A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. , 2009, Chemical communications.

[37]  Eric Meggers,et al.  Targeting proteins with metal complexes. , 2009, Chemical communications.

[38]  Charles Giardina,et al.  HDAC3 overexpression and colon cancer cell proliferation and differentiation , 2008, Molecular carcinogenesis.

[39]  J. Mariadason.  HDACs and HDAC inhibitors in colon cancer , 2008, Epigenetics.

[40]  C. Biot,et al.  Ferrocene Conjugates of Chloroquine and other Antimalarials: the Development of Ferroquine, a New Antimalarial , 2007, ChemMedChem.

[41]  Eric Meggers,et al.  Exploring biologically relevant chemical space with metal complexes. , 2007, Current opinion in chemical biology.

[42]  Ronald Breslow,et al.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug , 2007, Nature Biotechnology.

[43]  Andrew J. Wilson,et al.  Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer* , 2006, Journal of Biological Chemistry.

[44]  Sandra D'Angelo,et al.  Sodium nitroprusside: mechanism of NO release mediated by sulfhydryl-containing molecules. , 2005, Journal of medicinal chemistry.

[45]  J. R. Somoza,et al.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.

[46]  Minoru Yoshida,et al.  FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. , 2002, Cancer research.

[47]  D. Osella,et al.  On the mechanism of the antitumor activity of ferrocenium derivatives , 2000 .

[48]  H. Mehmet,et al.  Nitric oxide (NO.) and the nitrosonium cation (NO+) reduce mitochondrial membrane potential and trigger apoptosis in neuronal PC12 cells. , 1998, Biochemical Society transactions.

[49]  L. Miller,et al.  Oxidation of NADH by ferrocenium salts. Rate-limiting one-electron transfer , 1983 .